0000899243-21-004788.txt : 20210203
0000899243-21-004788.hdr.sgml : 20210203
20210203194826
ACCESSION NUMBER: 0000899243-21-004788
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210201
FILED AS OF DATE: 20210203
DATE AS OF CHANGE: 20210203
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Trager James
CENTRAL INDEX KEY: 0001816549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39370
FILM NUMBER: 21588204
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nkarta, Inc.
CENTRAL INDEX KEY: 0001787400
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474515206
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-215-0385
MAIL ADDRESS:
STREET 1: 6000 SHORELINE COURT
STREET 2: SUITE 102
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-01
0
0001787400
Nkarta, Inc.
NKTX
0001816549
Trager James
C/O NKARTA, INC.
6000 SHORELINE COURT, SUITE 102
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Scientific Officer
Common Stock
2021-02-01
4
M
0
2250
3.89
A
50672
D
Common Stock
2021-02-01
4
S
0
2034
38.07
D
48638
D
Common Stock
2021-02-01
4
S
0
1566
39.46
D
47072
D
Common Stock
2021-02-02
4
M
0
2800
18.00
A
49872
D
Common Stock
2021-02-02
4
S
0
2800
40.00
D
47072
D
Stock Option (right to buy)
3.89
2021-02-01
4
M
0
2250
0.00
D
2029-09-05
Common Stock
2250
59912
D
Stock Option (right to buy)
18.00
2021-02-02
4
M
0
2800
0.00
D
2030-07-08
Common Stock
2800
79600
D
The transactions reported in this Form 4 were effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 90 days prior to the trading date.
This transaction was executed in multiple trades at prices ranging from $37.71 to $38.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $39.00 to $39.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This option originally covered 62,162 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following September 5, 2019.
This option originally covered 82,400 shares of NKTX common stock and was scheduled to vest and become exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following July 9, 2020.
/s/ Alicia Hager, as attorney-in-fact
2021-02-03